Flanvotumab (Anti-TRP1 / TYRP1)
Flanvotumab (Anti-TRP1 / TYRP1) is a monoclonal antibody directed against the melanosomal membrane protein gp75 (or Tyrosinase-Related Protein 1 (TRP1)) with potential immunostimulatory and antineoplastic activities. MW: 145.5 kD.
Supplier | Selleck Chemicals |
---|---|
Product # | A2309 |
Sku # | A2309-1mg |
Pricing | 1mg, $270.00 |